Core Viewpoint - Aurora Cannabis Inc. is holding its annual general and special meeting on August 8, 2025, and shareholders are encouraged to vote in advance of the proxy voting deadline on August 6, 2025 [1][2][3] Company Information - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of brands, including adult-use brands such as Drift, San Rafael '71, Daily Special, Tasty's, Being, and Greybeard, as well as medical cannabis brands like MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co [4] - Aurora also has a controlling interest in Bevo Farms Ltd., which is North America's leading supplier of propagated agricultural plants [4] - The company's common shares are traded on NASDAQ and TSX under the symbol "ACB" [5] Voting Information - Shareholders are advised to vote their shares online or by telephone, following the instructions on their proxy forms [3][4] - For assistance with voting, shareholders can contact Laurel Hill Advisory Group, the company's proxy solicitation agent [4][7]

Financial Performance - Profit before tax (PBT) reached approximately VND 10.7 trillion in 1H25, a 2% year-over-year increase[93] - The Return on Equity (ROE) stood at approximately 20.6%, positioning ACB among the top-performing banks[27, 93] - Net Interest Income (NII) for 1H25 was VND 13043 billion, a 6% decrease year-over-year[33] - Non-Interest Income (NFI) grew by 39% year-over-year, reaching VND 4164 billion in 1H25, driven by investment and FX activities[39] Asset Quality and Growth - Credit growth was 9.1% year-to-date, with total lending reaching approximately VND 634 trillion[10, 93] - Deposit growth was 5.6% year-to-date, with total deposits reaching approximately VND 567 trillion[16, 93] - The Non-Performing Loan (NPL) ratio decreased to 1.27%[47] - The CASA ratio increased to 22.5% in Q2[20] Strategic Initiatives - The investment portfolio accounted for 16% of total assets[23] - Operating costs were effectively managed, maintaining the Cost-to-Income Ratio (CIR) at 32%[42, 43] - The bank launched a VND 2000 billion green/social credit package[90] Outlook - The company projects credit growth of +16%-18% vs 2024[95]

Core Viewpoint - Aurora Cannabis Inc. is set to announce its financial results for the first quarter of 2026 on August 6, 2025, and will host a conference call to discuss these results [1][5]. Group 1: Conference Call Details - The conference call is scheduled for August 6, 2025, at 8:00 a.m. Eastern Time and 6:00 a.m. Mountain Time [2]. - Miguel Martin, Executive Chairman and CEO, along with Simona King, CFO, will lead the conference call and Q&A session [2]. Group 2: Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Edmonton, Alberta, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3]. - The company offers a diverse portfolio of brands, including adult-use brands like Drift and San Rafael '71, and medical brands such as MedReleaf and CanniMed [3]. - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3]. Group 3: Stock Information - Aurora's common shares are traded on NASDAQ and TSX under the symbol "ACB" [4].

Industry Overview - The current moment presents a significant opportunity for marijuana stock investors, as legal cannabis remains a volatile sector with multi-state operators (MSOs) and ancillary companies leading the market [1][2] - Despite a decline in the sector's overall value, certain companies continue to achieve gains, indicating ongoing progress within the industry [1] Investment Potential - Long-term investing in cannabis stocks is seen as a speculative opportunity, with the potential for better reform and market conditions over time [2] - Historical trends suggest that positive news regarding cannabis reform has previously led to improved trading conditions for investors [2] Canadian Marijuana Stocks - Canadian marijuana stocks are highlighted as potential investments, particularly during a period when the majority of the sector is undervalued [3] - Investors are encouraged to conduct thorough research and develop a strategic plan to capitalize on potential recoveries in the market [3] Company Highlights - **SNDL Inc.**: Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada, with Q2 2025 earnings set to be reported on July 31 [4][6] - **Aurora Cannabis Inc.**: Involved in the production and sale of cannabis products, recently announced a charitable initiative donating 5% of net profits from specific products to veteran organizations, with a cap of C$200,000 [9][10] - **Village Farms International, Inc.**: Known for its innovative packaging approach through its subsidiary Pure Sunfarms, which aims to enhance consumer experience in cannabis shopping [11][12]

Insights gained from veterans participating in the program help guide the company in crafting custom cannabis strains, focusing on attributes such as aroma, appearance, and effects that matter most to veteran patients. Since its launch in 2022, there have been five purpose-grown strains developed within the Strains for Heroes lineup, and named by veterans, including, Valour, Courage, Honour, Esprit De Corps and United Victory. Aurora is proud to support a growing number of veteran-focused organizations, by ...

Industry Overview - The cannabis industry is currently facing challenges in the public sector, with a lack of momentum and upward trading, but the retail consumer side is performing well, indicating potential for future growth [1][2] - There is optimism among investors regarding federal reform and regulatory improvements, which could reignite interest in the sector [2] Investment Strategy - Investors are adopting a long-term buy-and-hold strategy, focusing on ancillary companies that are not solely dependent on cannabis for revenue, suggesting a shift towards patience and strategic planning [3] Company Highlights - **Cronos Group Inc.**: Engages in the cultivation, production, distribution, and marketing of cannabis products internationally, with recent expansion into the Swiss market through its PEACE NATURALS® brand [4] - **Aurora Cannabis Inc.**: Recently achieved EU-GMP Certification for its distribution center, enhancing its commitment to regulatory excellence and operational quality assurance [7] - **Canopy Growth Corporation**: Announced a strategic partnership with Commure to enhance healthcare staff safety, indicating a focus on healthcare-related applications of cannabis [9]

Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Information This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "cont ...

Core Points - Aurora Cannabis Inc. has filed and mailed the management information circular for the upcoming annual general and special meeting of shareholders [1] - The meeting is scheduled to be held virtually on August 8, 2025, at 1:00 p.m. Eastern time [2] - Shareholders are encouraged to vote their shares by the deadline of August 6, 2025, at 1:00 p.m. Eastern time [3] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of adult-use and medical cannabis brands, including Drift, San Rafael '71, MedReleaf, and others [4] - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4] Shareholder Engagement - Shareholders can access the management information circular on the company's website and are encouraged to watch a message from the CEO and CFO reflecting on fiscal 2025 [2] - The company emphasizes the importance of shareholder participation and provides contact information for assistance with voting [3]

Core Insights - Aurora Cannabis Inc. has launched two new proprietary cultivars in Poland, marking the highest potency medical cannabis products available in the country [1][2] - The new products, Farm Gas and Sourdough, are designed to meet the demand for high-quality, high-potency medical cannabis among prescribers and patients [2][3] - Aurora emphasizes its leadership in the international medical cannabis market, leveraging its scientific expertise and understanding of regulatory landscapes [3] Product Details - Farm Gas has a THC content of 27% and less than 1% CBD, with a unique aroma profile featuring notes of kerosene, diesel, and a sweet fruit sherbet finish [7] - Sourdough boasts a THC content of 29% and less than 1% CBD, characterized by sour, cake, and gasoline notes in its aroma profile [7] - Both cultivars are hang-dried and hand-finished, showcasing the company's commitment to quality [2] Company Overview - Aurora Cannabis Inc. operates in the medical and consumer cannabis markets across Canada, Europe, Australia, and New Zealand [4] - The company is known for its diverse brand portfolio, including both medical and adult-use cannabis brands [4] - Aurora holds a controlling interest in Bevo Farms Ltd., a leading supplier of propagated agricultural plants in North America [4]

Market Performance - Aurora Cannabis shares experienced a decline [1] - The company anticipates "temporary declines" in its international markets, including the U S [1]